Alpha-melanocyte-stimulating hormone modulates activation of NF-κB and AP-1 and secretion of interleukin-8 in human dermal fibroblasts

Annals of the New York Academy of Sciences

Volumn 885, Issue , 1999, Pages 277-286

  Böhm, Markus ^a   Schulte, Ursula ^b   Kalden, Henner ^b   Luger, T A ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; TRANSCRIPTION FACTOR AP 1;

ANGIOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MELANOCYTE; NEWBORN; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; WOUND HEALING;

EID: 0032804637     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08685.x     Document Type: Conference Paper

References (33)

1. 1. Hunt, G. et al. 1994. Cultured human melanocytes respond to MSH peptides and ACTH. Pigm. Res. 7: 217-221.
2. 2. Robbins, L.S. et al. 1993. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72: 827-834.
3. 3. Abdel-Malek, Z. et al. 1995. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. USA 92: 1789-1793.
4. 4. Thody, A.J. et al. 1975. Control of sebaceous gland function in the rat by α-melanocyte-stimulating hormone. J. Endocrinol. 64: 503-510.
5. 5. Lipton, J.M. et al. 1997. Antiinflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today. 18: 140-145.
6. 6. Van Der Reut, R. et al. 1992. Stimulation by melanocortins of neurite outgrowth from spinal and sensory neurons in vitro. Peptides 13: 1109-1115.
7. 7. Thody, A.J. et al. 1983. MSH peptides are present in mammalian skin. Peptides 4: 813-816.
8. 8. Slominski, A. et al. 1993. Detection of proopiomelanocortin-derived antigens in normal and pathological human skin. J. Lab. Clin. Med. 122: 658-666.
9. 9. Slominski, A. et al. 1995. Proopomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett. 374: 113-116.
10. 10. Wakamatsu, K. et al. 1997. Characterization of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigm. Cell Res. 10: 288-297.
11. 11. Nagahama, M. et al. 1998. Immunoreactivity of α-melanocyte-stimulating hormone, adrenocorticotrophic hormone and β-endorphin in cutaneous malignant melanoma and benign melanocytic naevi. Brit. J. Dermatol. 138: 981-985.
12. 12. Teofoli, P. et al. 1997. Proopiomelanocortin (POMC) gene expression by normal skin and keloid fibroblasts in culture: modulation by cytokines. Exp. Dermatol. 6: 111-115.
13. 13. Schauer, E. et al. 1994. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93: 2258-2262.
14. 14. Chakraborty, A.K. et al. 1996. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by UVB Biochim. Biophys. Acta 1313: 130-138.
15. 15. Chakraborty, A. et al. 1993. MSH receptors in immortalized human epidermal keratinocytes: a potential mechanism for coordinate regulation of the epidermal-melanin unit. Cell Physiol. 157: 344-350.
16. 7-α-melanocyte-stimulating hormone increased the eumelanin:phaeomelanin ratio in cultured human melanocytes. J. Invest. Dermatol. 104: 83-85.
17. 17. Chhajlani, V. et al. 1992. Molecular cloning and expression of the human melanocyte stimulating hormone receptors cDNA. FEBS Lett. 309: 417-420.
18. 18. Talwar, H.S. et al. 1995. Reduced type I and type III procollagens in photodamaged adult human skin. J. Invest. Dermatol. 105: 285-290.
19. 19. Lavker, R.M. et al. 1979. Structural alterations in exposed and unexposed aged skin. J. Invest. Dermatol. 73: 559-566.
20. 20. Fisher, G.J. et al. 1996. Molecular basis of sun-induced premature skin aging and retinoid antagonism. Nature 379: 335-339.
21. 21. Fisher, G.J. et al. 1997. Pathophysiology of premature skin aging induced by ultraviolet light. New Engl. J. Med. 337: 1419-1428.
22. 22. Kiss, M. et al. 1995. α-Melanocyte stimulating hormone induces collagenase/metallomatrix proteinase-1 in human dermal fibroblasts. Biol. Chem. Hoppe-Seyler. 376: 425-430.
23. 23. Schulte, U. et al. 1998. Evidence for a functional melanocortin receptor on human fibroblasts. Abstract. J. Invest. Dermatol. 110: 479.
24. 24. Englaro, W. et al. 1995. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J. Biol. Chem. 270: 24315-24320.
25. 25. Mitchell, P.J. et al. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245: 371-378.
26. 26. Benbow, U. et al. 1997. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15: 519-526.
27. 27. Siebenlist, U. et al. 1994. Structure, regulation and function of NF-κB. Ann. Rev. Cell Biol. 10: 405-455.
28. 28. Crawford, H.C. et al. 1996. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Prot. 49: 20-37.
29. 29. Chung, K.-Y. et al. 1996. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COLIA2) promoter activity by transforming growth factor-β. J. Biol. Chem. 271: 3272-3278.
30. 30. Manna, S.K. et al. 1998. α-Melanocyte stimulating hormone inhibits the nuclear factor transcription factor NF-κB activation induced by various inflammatory agents. J. Immunol. 161: 2873-2880.
31. 31. Mukaida, N. et al. 1994. Molecular mechanisms of interleukin-8 gene expression. J. Leukocyte Biol. 56: 554-558.
32. 32. Dunlevy, J.R. et al. 1995. Interleukin-8 induces motile behavior and loss of focal adhesions in primary fibroblasts. J. Cell. Sci. 108: 311-321.
33. 33. Hartmeyer, M. et al. 1997. Human microvascular endothelial cells (HMEC-1) express the melanocortin receptor type I and produce increased levels of IL-8 upon stimulation with α-MSH. J. Immunol. 159: 1930-1937.